Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Profit Margin (Quarterly) : -20.15K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -20.15K% |
| March 31, 2026 | |
| December 31, 2025 | -15.69K% |
| September 30, 2025 | -10.57K% |
| June 30, 2025 | -12.62K% |
| March 31, 2025 | -3.33K% |
| December 31, 2024 | -2.32K% |
| September 30, 2024 | -5.29K% |
| June 30, 2024 | -395.5% |
| March 31, 2024 | -1.05K% |
| December 31, 2023 | |
| September 30, 2023 | -6.71K% |
| Date | Value |
|---|---|
| June 30, 2023 | -1.52K% |
| March 31, 2023 | -640.8% |
| December 31, 2022 | -2.26K% |
| September 30, 2022 | -2.52K% |
| June 30, 2022 | -8.19K% |
| March 31, 2022 | -3.16K% |
| December 31, 2021 | -1.26K% |
| September 30, 2021 | -1.61K% |
| June 30, 2021 | -1.31K% |
| March 31, 2021 | -3.72K% |
| March 31, 2020 | -120.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Bicycle Therapeutics Plc | -8.00K% |
| Arbutus Biopharma Corp. | -507.2% |
| Moderna, Inc. | -539.3% |
| Adaptimmune Therapeutics Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.36% |
| Return on Assets | -7.87% |
| Return on Invested Capital | -8.18% |
| Gross Profit Margin (Quarterly) | 38.70% |
| Operating Margin (Quarterly) | -25.41K% |
| Return on Net Operating Assets | -421.0% |